TrialOpen heart2025
Phase 1 study of novel anti-platelet agent to overcome pharmacogenomic limitations of clopidogrel.
Anil Pareek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
TrialOpen heart2025
Anil Pareek et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.